Published on
July 21, 2026
- 17:15 GMT
Frontier Bio Wins Phase 1 of $7M NIH Challenge for AI-Powered Blood-Brain Barrier Testing
NeuroTraX-AI targets the blood-brain barrier, a central hurdle in brain medicine and drug safety, as U.S. regulators shift toward human-based testing HAYWARD, CA, UNITED STATES, July 21, 2026 /EINPresswire.com/ -- Frontier Bio, a biotechnology company …
Distribution channels:
Healthcare & Pharmaceuticals Industry
...
